ASIVA (AKU SIAP VAKSIN) AS AN EFFORT TO IMPROVE COMMUNITY KNOWLEDGE AND READINESS TO RECEIVE THE COVID-19 VACCINATION
Abstrak
Information that is not true or commonly called a "hoax" about the Covid-19 vaccine circulating in the community makes people restless and confused, and if this is not addressed immediately, more and more people refuse to be vaccinated. Health cadres have a role in educating the public about Covid-19 vaccination, but in reality their activities have been inactive during the pandemic. The ability to conduct health education by utilizing technology is still lacking, so it is necessary to provide training on how to conduct health education to cadres. The purpose of this activity is to increase the knowledge and readiness of health cadres in an effort to increase knowledge and readiness of the community to receive the Covid-19 vaccination through the ASIVa (Aku Siap Vaksin) program. The method used in this community service activity is a participative educational approach, namely providing health education to cadres about the Covid-19 vaccine and training on how to use technology for health promotion. This activity was carried out for one month and was attended by ten health cadres. The results of community service show that the knowledge of the cadres is very good, skilled and interactive in carrying out health education.Referensi
Chou, W. Y. S., & Budenz, A. (2020). Considering Emotion in COVID-19 Vaccine Communication: Addressing Vaccine Hesitancy and Fostering Vaccine Confidence. Health Communication, 35(14), 1718–1722. https://doi.org/10.1080/10410236.2020.1838096
Dror, A. A., Eisenbach, N., Taiber, S., Morozov, N. G., Mizrachi, M., Zigron, A., Srouji, S., & Sela, E. (2020). Vaccine hesitancy: the next challenge in the fight against COVID-19. European Journal of Epidemiology, 35(8), 775–779. https://doi.org/10.1007/s10654-020-00671-y
Halim, M., Halim, A., & Tjhin, Y. (2021). COVID-19 Vaccination Efficacy and Safety Literature Review. Journal of Clinical and Medical Research, 3(1), 1–10.
Hernawan Diana; Meylani, Vita; Agustian, Dita, E. H. (2021). Penyuluhan Dan Pelatihan Kader Desa Dalam Pencegahan Penularan Covid19. Abdimas Dewantara, 4(Vol 4, No 1 (2021)), 100–109. https://jurnal.ustjogja.ac.id/index.php/abdimasdewantara/article/view/8814/3912
Kemenkes RI, D. P. (2020). Keputusan Direktur Jenderal Pencegahan dan Pengendalian Penyakit Nomor Hk.02.02/4/1/2021 tentang Petunjuk Teknis Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID-19). Kementerian Kesehatan RI, 4247608(021), 114. https://www.kemkes.go.id/article/view/19093000001/penyakit-jantung-penyebab-kematian-terbanyak-ke-2-di-indonesia.html
Kementerian Kesehatan Republik Indonesia, ITAGI, WHO, & UNICEF. (2020). Survei Penerimaan Vaksin COVID-19 di Indonesia. Satuan Gugus Tugas Penanganan COVID-19, November.
Le, T. T., Andreadakis, Z., Kumar, A., Román, R. G., Tollefsen, S., Saville, M., & Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery, 19(May), 305–306. https://doi.org/10.1038/d41573-020-00073-5
Lin, Y., Hu, Z., Alias, H., & Wong, L. P. (2020). Knowledge , Attitudes , Impact , and Anxiety Regarding COVID-19 Infection Among the Public in China. 8(May), 1–7. https://doi.org/10.3389/fpubh.2020.00236
Lipsitch, B. M., & Dean, N. E. (2020). Understanding Covid-19 vaccine efficacy. 370(6518), 763–766.
Dror, A. A., Eisenbach, N., Taiber, S., Morozov, N. G., Mizrachi, M., Zigron, A., Srouji, S., & Sela, E. (2020). Vaccine hesitancy: the next challenge in the fight against COVID-19. European Journal of Epidemiology, 35(8), 775–779. https://doi.org/10.1007/s10654-020-00671-y
Halim, M., Halim, A., & Tjhin, Y. (2021). COVID-19 Vaccination Efficacy and Safety Literature Review. Journal of Clinical and Medical Research, 3(1), 1–10.
Hernawan Diana; Meylani, Vita; Agustian, Dita, E. H. (2021). Penyuluhan Dan Pelatihan Kader Desa Dalam Pencegahan Penularan Covid19. Abdimas Dewantara, 4(Vol 4, No 1 (2021)), 100–109. https://jurnal.ustjogja.ac.id/index.php/abdimasdewantara/article/view/8814/3912
Kemenkes RI, D. P. (2020). Keputusan Direktur Jenderal Pencegahan dan Pengendalian Penyakit Nomor Hk.02.02/4/1/2021 tentang Petunjuk Teknis Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID-19). Kementerian Kesehatan RI, 4247608(021), 114. https://www.kemkes.go.id/article/view/19093000001/penyakit-jantung-penyebab-kematian-terbanyak-ke-2-di-indonesia.html
Kementerian Kesehatan Republik Indonesia, ITAGI, WHO, & UNICEF. (2020). Survei Penerimaan Vaksin COVID-19 di Indonesia. Satuan Gugus Tugas Penanganan COVID-19, November.
Le, T. T., Andreadakis, Z., Kumar, A., Román, R. G., Tollefsen, S., Saville, M., & Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery, 19(May), 305–306. https://doi.org/10.1038/d41573-020-00073-5
Lin, Y., Hu, Z., Alias, H., & Wong, L. P. (2020). Knowledge , Attitudes , Impact , and Anxiety Regarding COVID-19 Infection Among the Public in China. 8(May), 1–7. https://doi.org/10.3389/fpubh.2020.00236
Lipsitch, B. M., & Dean, N. E. (2020). Understanding Covid-19 vaccine efficacy. 370(6518), 763–766.
Diterbitkan
2021-12-11
##submission.howToCite##
Septianingrum, Y., Wijayanti, L., & Sulistyorini, S. (2021). ASIVA (AKU SIAP VAKSIN) AS AN EFFORT TO IMPROVE COMMUNITY KNOWLEDGE AND READINESS TO RECEIVE THE COVID-19 VACCINATION. Community Service Journal of Indonesia, 3(2), 41-46. https://doi.org/10.36720/csji.v3i2.334
Bagian
Articles
##submission.copyrightStatement##
##submission.license.cc.by-nc4.footer##Authors who publish with Community Service Journal of Indonesia agree to the following terms:
- Authors retain copyright licensed under a Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0), which allows others to remix, tweak, and build upon the authors' work non-commercially, and although the others' new works must also acknowledge the authors and be non-commercial, they don't have to license their derivative works on the same terms.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). Authors can archive pre-print and post-print or publisher's version/PDF.
